Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | GJB2 | P29033 | 2/20 | 0.40 |
| ▸ | NT5E | P21589 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.39 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.39 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.39 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18640660 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL18852547 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL22316285 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL17040223 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL29937530 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL19380966 | 1.00 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL20140085 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL18485164 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL19891743 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A | |
| SCHEMBL18822660 | 0.97 | BCHE (0.55) | BCHEACHESLC6A2PDE4DHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3184112-B1 | SYNTHETIC INTERMEDIATE OF 1-(2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSYL)CYTOSINE | FUJIFILM CORP (JP) | 2020-12-23 | — | — | EP | disclosed |
| US-10597414-B2 | Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2λ5-[1,2]oxaphosphinane | PHOST'IN (FR) | 2020-03-24 | — | — | US | disclosed |
| US-10570112-B2 | Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same | FUJIFILM CORPORATION (JP) | 2020-02-25 | — | — | US | disclosed |
| US-20190330252-A1 | CRYSTALLINE POLYMORPHIC FORM OF 3-HYDROXY-4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-PHENYL-2-0X0-2LAMBDA5-[l ,2]0XAPHOSPHINANE | PHOST'IN (FR) | 2019-10-31 | — | — | US | disclosed |
| US-9663548-B2 | 10-α/β-D-arabinofuranosyl-undecenes as potential anti-mycobacterial agents and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570112-B2 | Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same | TYMS, TYMP, RRM2B | BCHE 3683/4885ACHE 3475/4885SLC6A2 2644/4885 |
| US-20190330252-A1 | CRYSTALLINE POLYMORPHIC FORM OF 3-HYDROXY-4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-PHENYL-2-0X0-2LAMBDA5-[l ,2]0XAPHOSPHINANE | CYP3A5, CYP4B1, SF3B5 | BCHE 2549/4885ACHE 4782/4885SLC6A2 2369/4885 |
| US-10597414-B2 | Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2λ5-[1,2]oxaphosphinane | IPO5, SF3B5, CYP3A5 | BCHE 2890/4885ACHE 4774/4885SLC6A2 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.